drug approval

Blue background with pill pattern with the words The Top Line
Podcast

Unpacking the FDA transparency push on CRLs

This week on “The Top Line,” we unpack how the FDA’s approach to CRL disclosure is evolving—and what the new timing and scope mean for biopharma.